Meet with our product experts in one-on-one virtual sessions
对我们的产品有疑问? 我们将尽早回复
Current Landscape of Cancer Treatment in India and Dr. Reddy's Role in Enhancing Care
Harnessing India's New Drug Development Capabilities for Global Impact
Global Development Strategy for Generic Formulations and APIs
APIs for Emerging Markets: Opportunities and Challenges
Celebrating Creativity and Festivity: API Calendar Launch 2025!
Dr. Reddy's API team at CPHI Milan 2024
Dr. Reddy’s wins CPHI & PMEC India Award for Excellence in Ancillary Pharma Services - Supply Chain & Logistics for enhancing customer experience
Dr. Reddy’s wins CPHI & PMEC India Award for developing a continuous API manufacturing process.
Dr. Reddy's API team at CPHI India 2024
Formulation Strategies and Pharmaceutical Analysis for Anti-diabetic APIs
Our experts will answer your questions, provide advice, and help you understand our product better
本目錄中的任何信息(包括對任何產品或服務的任何引用)均不構成銷售要約,或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是,只要存在此類監管豁免,就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估,並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途,但可用於第 107A 節。